Clinical Research Staffing stock photo
October 12th, 2015

Four Ways to Use Apprentices to Improve Food Quality

There are Four Ways to Use Apprentices: to help reduce the risk of a recall, help pass third party certification audits, fix root causes of complaints, and reduce the cost of manufacturing. The impact on your business bottom line can be tremendous. Here are some ways apprentices are currently being used by our clients:

  • Apprentices can be used to pass third party certifications. This would allow you to land additional clients (make a list). Retailers and other manufacturers often require their Read the rest of this entry »
October 7th, 2015
FSMA Food Safety Modernization Act

FSMA Food Safety Modernization Act insures the quality and safety of our food supply.

FSMA Half Day Workshop Attendees Give 4.6 Stars

Did you make the QLN FSMA half day workshop in Irvine? The 97 attendees seemed extremely satisfied with the Sept 24th, 2015 event, giving it an overall rating of 4.6 (scale 1-5).

Easy FSMA Launched

EasyFSMA website www.easyfsma.com was launched by the Quality Leadership Network (QLN) members, which includes Rosemarie Christopher, our CEO. as a venue to disseminate information about the Food Safety Modernization Act (FSMA) and other Read the rest of this entry »

August 17th, 2015

FSMA Compliance Workshop 2015

 

FSMA Compliance Workshop

Download the PDF flyer

FSMA will impact your food business. Find out how and what to do about it. This is a free half day workshop on Food Safety and Modernization Act (FSMA) compliance.

Breakfast and refreshments are sponsored by the American Society for Quality (ASQ) Food, Drug & Cosmetic Division, the Quality Leaders Network (QLN) Food Group, RxRS Apprenticeship Program and Food Safety Net Services.

Overview

FSMA is designed to insure food quality from the farm to fork. FSMA requires all Read the rest of this entry »

July 30th, 2015

Apprentices Available

Apprentices available to build a fresh new pool of talent in Quality, Regulatory, Clinical and Medical roles for Food, Biotech, Pharmaceutical and Medical Devices. Our grants cover part of the cost of training and employing apprentices while they work toward an industry certification, typically one or two years.  We currently have two Read the rest of this entry »

January 8th, 2015

2015 Southern California Food Industry Conference

Button Up for the Winds of Change 

Labels, Regulations, and Consumer Expectations

 

Wednesday March 4, 2015 9am – 3pm Read the rest of this entry »

September 30th, 2014

Understanding How FDA Looks at Outsourcing

When:  Thursday, October 9, 2014 at 6:00 PM

Where:  The Wyndham, 17941 Von Karman Ave., Irvine, CA 92614

Read the rest of this entry »

April 8th, 2014

ASQ Quality and Safety Conference Features Food, Drug, Cosmetic Experts

Quality and Safety ConferenceWCC PR v2

March 10th, 2014

ASQ March 2014 Roundtable – Risk Based Environmental Monitoring (EM)ASQ Biomedical Division


This message is sent by the Southern California Discussion Group of the Biomedical Division of ASQ of the American Society for Quality as a benefit of your membership.

____________________________________________________________________

The Southern California Discussion Group of the ASQ Biomedical Division Presents:

Risk Based Environmental Monitoring (EM)  

How to use risk to ensure your EM Program is value added & efficient

           An Industry Roundtable Discussion   

                      

Tuesday, March 25, 2014
5:30pm to 8:30pm Read the rest of this entry »

February 26th, 2014

ASQ HDL Webinar: Facts Tell and Stories Sell

Webinar on February 26 Read the rest of this entry »

February 14th, 2014

CAPA and Root Cause Analysis

Orange County Regulatory Affairs Discussion Group

Wednesday, March 5, 2014
8:00 am – 5:00 pm Read the rest of this entry »

October 7th, 2013

TENURE TRACK POSITION IN FOOD QUALITY AND PROCESSING

 

The Food Science and Nutrition Department at Cal Poly, San Luis Obispo, CA is seeking a full-time, academic year, tenure-track position beginning January 6, 2013. For details, qualifications, and application instructions (online faculty application required), visit WWW.CALPOLYJOBS.ORG and refer to Requisition #102980 . Review Begin Date: October 15, 2013. EEO

August 16th, 2013

Quality Management Systems

presented by Marianne Silva

This meeting is appropriate for those people in the medical products, clinical laboratory and food products industries who are currently developing or wish to improve the compliance or effectiveness of their company’s Quality Management System.

REGISTER HERE

The presentation on August 20th will provide:

  • An introduction to Quality Management Systems
  • Regulatory references for Quality Management System requirements
  • Discussions will include the application of Quality Management Systems as they relate to biologics, medical device, the food and supplement industries and the clinical laboratory environment.

Agenda

  • 5:30 pm – Registration and Networking
  • 5:45 pm – Dinner
  • 6:00 pm – Welcome and Introduction
  • 6:15 pm – Speaker
  • 7:45 pm – Break
  • 8:00 pm – Q&A Session
  • 8:15 pm – Raffle and VOC Survey
  • 8:30 pm – Adjournment

*Dinner is included with registration

Marianne’s presentation will focus on Quality Management Systems, references for Quality Management System requirements, and how to apply Quality Management systems to biologics, medical devices, clinical laboratories, and the food and supplement industries.

Marianne Silva is the Manager of Quality, Regulatory and Compliance for the USC Clinical Laboratories, Keck Hospital of USC and USC Kenneth Norris Jr. Cancer Hospitals. Marianne has a Masters Degree in Medical Technology, Immunohematology and Education in coordination with her SBB (Specialist in Blood Bank) training over 35 years ago. She was the Compliance Officer for a licensed blood center, the Compliance Officer for the Division of Transfusion Medicine at UCLA Medical Center, and the Instructor for medical technology students, teaching at California State University, Los Angeles for almost 10 years. Marianne is a Certified Quality Auditor and has over 35 years of experience in the Transfusion Medicine environment with an emphasis on regulations, accreditation, quality systems and compliance issues. Marianne worked for AABB Consulting Services Division, providing quality and regulatory solutions to clients across the United States and Canada.

Marianne has published multiple articles and a text on Quality, and has provided presentations at the local, state, national and international levels.

 

August 9th, 2013

Successfully Build Productive Teams

 

 Manage Personalities While Navigating Workplace Politics

Join us for an ASQ HD&L Hosted Webinar on Tuesday, August 13 4:00pm-5:00pm PST

Space is limited. Reserve your Webinar seat now at: https://www4.gotomeeting.com/register/836839199

Whether you are building a new team, or simply adding new members to an already existing team, choosing the right people is of the upmost importance. Personalities matter as much as technical skills and the right person can enhance your team, while the wrong person can change the culture of your team and decrease overall productivity.

Rosemarie Christopher is a graduate of the University of Southern California (USC) with a MA in Communication Management and the University of California Los Angeles (UCLA) with a BA in Anthropology. She holds board member positions in various quality and regulatory organizations such as the American Society for Quality (ASQ) Food, Drug and Cosmetic (FDC) as Division Chair, National Discussion Group Chair, Region 7 Deputy Regional Director and Section Career Development and Education Chair; the USC School of Pharmacy as a member of the Board of Councilors and Executive Committee Chair of the Life Sciences Council; the Orange County Regulatory Science Discussion Group as a Board Member. As the President & CEO of MEIRxRS, a family of companies that recruit and staff technical and scientific STEM professionals, Rosemarie has over 25 years of experience in employment, on the job training and retention of multigenerational workforce.

Title: Successfully Build Productive Teams: Manage Personalities While Navigating Workplace Politics
Date: Tuesday, August 13, 2013
Time: 4:00 PM – 5:00 PM PDT

After registering you will receive a confirmation email containing information about joining the Webinar.

System Requirements
PC-based attendees
Required: Windows® 7, Vista, XP or 2003 Server

Mac®-based attendees
Required: Mac OS® X 10.6 or newer
Mobile attendees
Required: iPhone®, iPad®, Android™ phone or Android tablet

April 11th, 2013

2013 Workshop – Marketing of FDA Regulated Products

FDA Centers, FDA Los Angeles District Office and the Orange County Regulatory Affairs Discussion Group Present The 16th Annual FDA-OCRA Educational Conference

June 12-13, 2013

Irvine Marriott
18000 Von Karman Avenue, Irvine, CA 92612 (949) 553-0100

The FDA-OCRA Educational Conference is a unique event co-sponsored by the FDA and OCRA, that affords you maximum interaction with both Los Angeles District and Washington-based FDA personnel. Over the years, the collaborative efforts of FDA and OCRA have brought FDA and Industry staff together for this Educational Conference.

Who Should Attend
* Regulatory Affairs/Compliance
* Clinical Affairs/Auditors
* Legal Staff
* Quality Affairs/Quality Control
* Marketing & Advertising
* Product Development
* Consultants & Analysts
* Operations & Management
Keynote Address:
What Went Wrong?
Tales from FDA’s Office of Criminal Investigations (OCI)
Special Agent Keith Hadley, from FDA’s Office of Criminal Investigations, will discuss criminal aspects of non-compliance.

Plenary topics:
* Food & Drug Administration Initiatives for 2013 and “Hot” Topics:
An Agency Perspective
* FDA and FTC Guidance on Social Media:
Innovative Marketing v. Control
* Border Protection: What happens if Your Product is Imported or
There are Suspicious Imports?
* Inspection Mitigation: Avoiding Escalation
* Business Disruption & Resumption Planning After a Disaster:
Real Life Experience and Agency Expectations
* Federal and State Marketing: Sunshine Laws
* Q&A Panel Sessions with all Speakers

Three Separate Breakout Sessions:
1. Medical Devices & IVDs:
* CDRH Update: Hot Topics, Changing Guidance & Expectations,
Partnering: The MDIC Experience
* Federal and State Marketing: Sunshine Laws
* UDI: Implementation and Impact on Industry
* Clinical Trials for Medical Devices: Key Priorities and Activities
* Case for Quality: What are Responsibilities of
Manufacturers/Distributors and FDA’s Next Steps
2. Drugs/Biologics/OTC/Generics:
* Marketing Applications: FDA Review Practices and
Preparation of Global CMC Submissions
* Generic Drugs and Biosimilars Update
* Quality by Design: How Well does Pharma Meet
Deming’s 14 Points?
3. Food/ Dietary Supplements:
* CFSAN and Industry Update
* GMP Issues: Updates, Inspections, Recent Enforcement Activity
* Labeling and Claims
* Dietary Supplements Case Studies and Expert Panel Discussion

Register Online
Be sure to log on or create a new user profile before registering
http://www.ocra-dg.org/

SCHEDULE

Wednesday, June 12, 2013

7:00 – 8:00 am
Registration and Continental Breakfast

8:00 – 8:30 am
Opening Remarks by Conference Chairs and OCRA President
Alonza E. Cruse, B.S., District Director, FDA Los Angeles District
Regina O’Meara, Principal, Global IVD Regulatory Consulting
Ginger Clasby, VP Clinical & RA, Transcend Medical, Inc.
8:30 – 9:20 am
Keynote Address:
Real Life Stories from FDA’s Office of Criminal Investigations
Moderator:
Regina O’Meara, Principal, Global IVD Regulatory Consulting
Speaker:
Keith Hadley, Special Agent, FDA’s Office of Criminal Investigations (OCI)
Agent Hadley will discuss criminal aspects of non-compliance.

9:20 – 9:45 am
Break

9:45 – 10:45 am
Food & Drug Administration Initiatives for 2013 & “Hot” Topics:
An Agency Perspective
Moderator:
Alonza E. Cruse, B.S., District Director, FDA Los Angeles District
Speaker:
FDA Speaker Invited
10:45 – 11:45 am
FDA and FTC Guidance on Social Media:
Innovative Marketing v. Control
Moderator:
Michael J. Wagner, Esq., Regulatory Counsel, Focus Diagnostics
Speakers:
FDA Speaker Invited
Eric Goldman, Professor of Law and Director of the High Tech
Law Institute, Santa Clara Law School
This session will cover the following on social media:
* Agency current expectations
* Status of FDA Guidance
* Tools available to monitor social media
* Online Accountability for manufacturers, distributors and packers
* Using Links on the Internet
11:45 am – 1:00 pm
Lunch

1:00 – 2:00 pm
Inspection Mitigation: Avoiding Escalation
Moderator:
Yasamin Ameri, RAC, Consultant, Quest International Consulting
Speakers:
Dr. Raymond W. Brullo, DPM, FAPWCA, Compliance Officer
FDA Los Angeles District
Jack Sorokin, Esq. Invited
This session will cover the following:
* Addressing potential findings during an inspection
* Responding to inspectional findings
* Meeting with the District
* Estimating Agency expectations and meeting them
* Not all inspections go smoothly and the are different levels of findings
* How does a firm ensure that corrective actions meet the FDA expectations and what are some practical tips for avoiding enforcement escalations

2:00 – 3:00 pm
Business Disruption & Resumption Planning After a Disaster:
Real-Life Experience and Agency Expectations
Moderators:
Esther Y. Kim, Esq, Director of Legal/Compliance, Pharmavite LLC
Del Stagg, PhD, Regulatory Affairs and Quality Consultant
Speakers:
Tanya Malais, National Emergency Response Coordinator, FDA
Robert Takemura, Partner, MLC & Associates, Inc.
This session will cover:
* Identifying potential disasters
* Business impacts following a disaster
* FDA expectations after a disaster

3:00 – 3:15 pm
Break

3:15 – 4:15 pm
Border Protection – What Happens if Your Product is Imported or There are Suspicious Imports?
Moderator:
Linda Hartley, Program Support Specialist, FDA Los Angeles District
Speaker:
Dan Solis, Director of Import Operations, FDA Los Angeles District

4:15 – 5:00 pm
End of Day Open Panel Discussion with All Speakers
Moderator:
James R. Lusk, RAC, Principal, Quality Systems International
5:00 – 8:00 pm
After Conference Reception
OCRA’s Member Appreciation Night
All attendees invited at no additional cost
Click Here to Download the Registration Form

SCHEDULE
Thursday, June 13, 2013
7:00 – 7:50 am
Networking Breakfast
Attendees will be broken into interest groups to discuss and strategize current industry challenges. We will have separate tables for the following groups:

* Medical Devices
* IVDs
* Drugs and Biologics
* Dietary Supplements

Note: The remainder of the day will be breakout sessions. There are three tracks to choose from:
Medical Devices and IVDs
Drugs, Biologics, OTC and Generics
Food and Dietary Supplements

Medical Devices and IVD
Breakout Sessions
8:00 – 9:15 am
Session #1: CDRH Update
Speakers:
FDA Speaker Invited
Mark DuVal, JD, President, DuVal & Associates
* Hot Topics
* Changing Guidance and Expectations
* Partnering: The Medical Device Consortium Experience

9:15 – 10:30 am
Session #2: Federal and State Marketing: Sunshine Laws
Moderator:
Elaine Messa, Director, Medical Device Quality Systems
Industry Speakers Invited
* What are Sunshine Laws?
* Reporting responsibilities of manufacturers
* Elements of marketing compliance plan
* What about the future and federal pre-emption?
* Covers marketing, sales and distribution
* Q & A
10:30 – 10:45 am
Break

10:45 am – 12:15 pm
Session #3: UDI (Unique Device Identifier):
Implementation and Impact on Industry
Moderator:
James “Rusty” Lusk, Principal, Quality Systems International
Speakers:
FDA Speaker Invited
Dawn Fowler, Sr. Manager of Global Labeling/Document Control,
Endologix
Everything you ever wanted to know, and more, about UDI
We know that:
* Not all suppliers are the same
* Not all manufacturers are the same
* Not all users are the same
* Not all points of use are the same

We also know that all the above and more, have a need to share the identical information across their points of contact. The UDI is the glue that binds the information into a format that is universally understandable and instantly available at all there interfaces.
Different needs may have different approaches:
* I have one high product. Why all the fuss?
* I have a bazillion sku’s- where do I start?

This session will cover:
* Format Options- why chose one over the other?
* General structure requirements
* Equipment Options
* Implementation successes and pitfalls
* Big Company versus Small Company approaches
* How much will this cost?

12:15 – 1:00 pm
Lunch

1:00 – 3:00 pm
Session #4: Clinical Trials for Medical Devices
Moderators:
Ginger Clasby, VP Clinical & RA, Transcend Medical, Inc.
Terrie Hopton, Mgr, Business Development, Promedica International
Speakers:
James R. Fleckenstein, Investigator, FDA, Los Angeles District
Christian Burns, Director, Clinical Operations & Marketing, ClinEdge
Lucinda Marinus, Clinical Data, Manager, Transcend Medical
Jodi Aiken, VP, Global Clinical Affairs, Transcather Heart Valve
Therapy, Edwards Life Sciences
In this session, we will discuss several key priorities and activities associated with planning and implementing medical device clinical trials, with an emphasis on:
* Unique considerations associated with finding and recruiting study subjects to participate in medical device clinical trials
* Considerations and best practices for collecting and analyzing clinical study data
* Risk-based monitoring of study progress and conformance with regulatory requirements

3:00 – 3:15 pm
Break

3:15 – 4:15 pm
Session #5: Case for Quality
Moderator: Eri Hirumi, RAC, Regulatory Affairs Manager, Beckman Coulter, Inc.
Speakers: FDA Speaker Invited
This session will cover:
* Background of the Initiative
* Why it’s important
* What are responsibilities of manufacturers and distributors?
* FDA’s next steps
Drugs, Biologics, OTC and Generics Breakout Sessions

8:00 – 9:30 am
Session #1: Marketing Applications: FDA Review Practices and Preparation of Global CMC Submissions
Moderator:
Cindy Fisher, PhD, RAC, Associate Director, Regulatory Affairs, Vical
Speakers:
Industry Speaker Invited
What does FDA look for in marketing applications? A CBER review team member will provide insights into how FDA reviews marketing applications and helpful hints on making your application process run more smoothly.
In today’s global economy, many companies are filing products internationally. With varying in-country requirements and varying IP protection around the world, what are the best practices for managing global CMC submissions?
This session is sponsored by the OCRA CMC Discussion Group.

9:30 – 9:45 am
Break

9:45 am – 12:00 pm
Session #2: Generic Drugs and Biosimilars Update
Moderator:
Michael A. Swit, Esq., Special Counsel, Duane Morris, LLP
Speakers:
FDA Speaker Invited
With the enactment of the Generic Drug User Fee Act (GDUFA), FDA’s Office of Generic Drugs (OGD) may finally have the resources it needs to address both the significant backlog in pending applications and the timelines for approval of generic drug applications. This session will explore how OGD is marshaling these new resources and dealing with other key issues evolving in the generic drug approval process, including citizen petitions challenging generic approval standards and a potential regulation that would impose new pharmacovigilance duties and labeling revision obligations on generic manufacturers. For anyone concerned with generic drugs, whether from a brand or generic perspective, this is an essential session.

12:00 – 1:00 pm
Lunch

1:00 – 4:15 pm
Session #3: Quality by Design (QbD): How Well Does Pharma Meet Deming’s 14 Points?
Moderator:
Ali M. Afnan, PhD, President, Step Change Pharma, Inc.
Speakers:
FDA Speaker Invited
Kevin R. Cahill, Executive Director, The W. Edwards Deming Institute
Ali M. Afnan, PhD, President, Step Change Pharma, Inc.
Michelle Howard-Sparks, Associate Director of Solid Formulations
Millenium Pharmaceuticals Invited
This session will delve into the application of W. Edwards Deming’s 14 Points for Management to the pharmaceutical industry. In the first half of the session, Kevin Cahill, VP of The Deming Institute and Deming’s grandson, will provide a primer on the Deming’s 14 Points and the philosophy behind them. The second speaker, Ali Afnan, will discuss the applicability and incorporation of Deming’s total quality management approach in the pharmaceutical arena.
In the second half of the session, the FDA will examine the application of statistical quality control techniques to ensure the quality of pharmaceutical products. Finally, an industry speaker will examine the incorporation of Deming’s concepts to the management of development and risk in a pharmaceutical setting.

2:30 – 2:45 pm
Break

QbD Session continues after the break.
Food/Dietary Supplements
Breakout Sessions

8:00 – 10:00 am
Session #1: CFSAN and Industry Update
Moderator:
Vicki Whitsitt, Mgr, Scientific/Regulatory Affairs,
Natural Products Association
Speakers:
FDA Speaker Invited
Cara Welch, PhD, VP Scientific/RA Natural Products Association
Michael McGuffin, President, American Herbal Products
Association (AHPA) Invited
This session will feature an update from FDA on industry hot topics their current priorities and hear from two industry associations address the challenges facing dietary supplement companies both on Capitol Hill and on the regulatory front. While GMPs continue to be in the forefront, it’s not just about GMPs – speakers will also touch topics such as adverse event reporting, the draft NDI guidance, FSMA proposed rules, import/exports, adulterated ingredients, etc.

10:00 – 10:15 am
Break

10:15 – 11:45 am
Session #2: GMP Issues
Moderator:
Timothy Stewart, PhD, Consultant, QSD Consulting Group
Speakers:
FDA Speaker Invited
Cindy Beehner, President, QSD Consulting
This session features an update from FDA on its recent GMP-related enforcement activities and inspection findings and insight from an industry consultant about addressing the most common problems and how to effectively respond to 483 observations.

11:45 am – 12:45 pm
Lunch

12:45 – 2:30 pm
Session #3: Labeling and Claims
Speakers:
FDA Speaker Invited
Industry Attorney Invited
Supplement labels and claims continue to be a concern to FDA and a source of numerous warning letters. Hear from FDA about the basic regulatory requirements for product labeling and claims for your products. The industry attorney will discuss how to properly position your product in the marketplace, discuss Prop 65 issues, and discuss how product labeling is causing companies to become part of class action suits.

2:30 – 2:45 pm
Break

2:45 – 4:15 pm
Session #4: Dietary Supplements Case Studies
and Expert Panel Discussion
All Speakers Are Asked To Join the End of Day Panel
This session will begin with a group activity of case studies on various scenarios related to current industry issues. The individual groups will share summaries of their case studies, and then it will be open to discussion from the group as a whole and input from the expert panel of speakers.

About OCRA
OCRA, Orange County Regulatory Affairs Discussion Group, is a non-profit volunteer organization composed of Regulatory Affairs professionals from the Southern California area who are interested in participating in educational programs and networking with one another. Our membership includes individuals who work in Life Sciences industries such as medical devices, pharmaceuticals, biologics, IVD, dietary supplement, food and cosmetics.

OCRA has over 850 members representing more than 225 companies in Orange County and surrounding areas. Our members represent companies of all sizes and complexities.

OCRA meetings provide an educational forum and a means for the regulatory community to network. While our focus is regulatory in nature, our programs have also provided timely information for individuals involved in Engineering (software validation and product development), Marketing (advertising and labeling), Quality (Quality System Regulation), and other related fields.

Gift Bag Giveaways and Sponsorships Available
Contact Kimberly Syre at ksyre@cox.net to inquire about sponsorship opportunities.

REGISTRATION INFORMATION
The 16th Annual FDA-OCRA Educational Conference
Applying Regulatory Science to the Marketing of FDA Regulated Products
June 12-13, 2013 at Irvine Marriott
For an Immediate Receipt, Please Use the On-Line or PayPal Option
http://www.ocra-dg.org/
REGISTRATION RATE
$ 725 OCRA Members
$ 775 Non-members (includes OCRA membership for one year)
$ 475 FDA/Government/Students*

ONE DAY RATE:
$ 425 OCRA Members
$ 475 Non-members (includes OCRA membership for one year)
$275 FDA/Government/Students*

* Student Rate is for individuals enrolled full time in a Regulatory or Quality related academic program at an accredited institution. The Student Rate does not apply to working professionals taking one or two courses on the side. Student ID and copy of current class schedule are required to register at this rate. Final eligibility determined by OCRA.

INSTRUCTIONS TO REGISTER ONLINE:
Log onto the OCRA website (http://www.ocra-dg.org/) with your username and password OR Create a new account by selecting “Register” on the top right hand side. If you are not an OCRA Member, it will ask you to join. Please keep in mind that to attend any OCRA meeting, we require you to become a Member.

March 14th, 2013

Delivering breakthrough product & process performance

The Southern California Discussion Group of the ASQBiomedical Division Presents:     

 

Design of Experiment:

Delivering breakthrough product & process performance

           An Industry Roundtable Discussion   

                       Read the rest of this entry »

March 8th, 2013

Delivering breakthrough product & process performance

The Southern California Discussion Group of the ASQ Biomedical Division Presents:     

 

Design of Experiment:

Delivering breakthrough product & process performance

           An Industry Roundtable Discussion   

                      

Thursday, March 21, 2013
5:30pm to 8:30pm

 

   

Topic:   

Utilizing a key six sigma tool, DOE to optimize product & process performance

Design of Experiments (DOE) is used to dramatically improve product and process innovation, effectiveness, and efficiency. DOE is the scientific approach used by researchers to build empirical mathematical models of product and process performance. These models are formulas that are used to optimize product and process performance while significantly reducing costs. DOE is considered the most powerful Six Sigma optimization tool and the Global Harmonization Task Force (GHTF) strongly encourages its use during medical device development.

Takeaways:

*  Understanding DOE (DOE VS One-Factor-at-a-Time VS Taguchi)

*  Learn how to create & analyze a factorial experiment

*  Learn how to optimize product and process performance while reducing variation and costs

Please bring your questions, experiences, and other commentary to make this a more valuable experience.

 

 

Expert: 

Ned Schneider     

Ned Schneider is a consultant and trainer with Advanced Response Engineering and has 20+ years medical device industry experience as an engineer and Director of Engineering working for several leading technology companies. Ned has compiled many Corporate Awards, Patents and ROIs over the course of his engineering career and has a B.S.M.E. & B.S. Industrial Engineering and Management. Ned provides engineering consulting and teaches ASQ Certification Refresher Classes for the Certified Six Sigma Black Belt and Certified Quality Engineering Programs. Also, for the past 6 years, he has taught Design of Experiments for both UC Irvine and UC San Diego through their Extension & Corporate Training Programs. He is an ASQ Certified Six Sigma Black Belt and Certified Quality Engineer with considerable expertise in the areas of product development, process development and automation.

 

 

To Register:

 http://www.acteva.com//booking.cfm?bevaid=235417

Registration:

Dinner & drinks will be provided.   

Seating is limited to the first 40 registrants, so sigh up soon!  

Registration closes at noon event day.  

Location:   Abbott Medical Optics 

                  1700 E. Saint Andrew Place, Santa Ana, CA  92705     

 

Member      

Early Registration $20- / After March 18th $25 

 

Non-member  

Early Registration $30- / After March 18th $35 

Students

Early Registration $15-  

(must show valid School ID at event registration table for entrance) 

 

Walkins $35- (cash only) if seating is available

 

 Click Here to Download the Event Flyer  

 

For more information, contact:

Tiffany Abrams at (714) 247-8572 or email:

Tiffany.Abrams@amo.abbott.com

 

As volunteers in a not-for-profit professional organization ASQ Biomedical, SCDG (Southern California Discussion Group) is committed to providing low cost high value events for biomedical professionals and the local community.  We are able to keep our costs low by utilizing a registration system that incurs minimal administrative overhead expenses and minimizes excess time and effort spent by our volunteers to bring you these events.  Please help us continue providing low cost quality programs to you by using the system that works well for us.  If you do not wish to use the registration system to preregister, you may attempt to register at the event, however seating is limited therefore entrance and/or food can not be guaranteed.  Also, due to the nature of the low pricing scheme and the registration system used, we are unable to perform refunds.

January 29th, 2013

Current Trends in Good Manufacturing Practice

ASQ Orange Empire Presents….

Current Trends in Good Manufacturing Practice

This workshop is designed for anyone working in the FDA regulated industries and requires a comprehensive understanding of the basic concepts of Good Manufacturing Practice. FDA regulated industries includes pharmaceuticals, medical devices, blood products, biologics, dietary supplements,

cosmetics, and foods.

Some Workshop Highlights:

  • Identifying and overcoming the challenges associated with implementing effective written procedures
  • Developing recommendations to prevent audit observations
  • Conducting a mock GMP/QSR audit
  • An inside look at the FDA and how they operate
  • The why behind the GMP regulations. Exploring the intent of the regulations
  • How and why GMP makes Good Business Sense
  • And much more!

About the Speaker: David Markovitz

David Markovitz has over three decades of leadership and management experience in the health care industry. Having held positions as Manufacturing Laboratory Manager, Packaging and Filling Manager, Pilot Plant Manager, Manufacturing Engineer, Technical Training Manager, and Corporate Director of Education and Training, he has hands-on experience in effectively managing complexity with limited resources. David’s corporate experience was acquired at Nutrilite Products, SmithKline Beckman, Organon Diagnostics, and Ortho Diagnostics. David is the President of GMP Training Systems, an education, training, and consulting firm whose mission is to help organizations improve their productivity, quality, and long-term profitability by implementing strategies focused on innovation, continual improvement and optimization of work systems and processes throughout all levels in an organization.

David had the rare privilege of assisting Dr. W. Edwards Deming, the 20th century’s leading quality guru, in several of his famed Four-Day Seminars. David created and led the Deming Roundtable, an intensive year-long cooperative effort involving eight different organizations working to implement Deming’s teachings.

An internationally recognized and award winning speaker and workshop leader, David has been invited to present at conferences and meetings throughout the world. He is the recipient of the Gold Microphone Award (National Speaker Association) and the 2004 winner of the prestigious Connie Award for Professionalism on the Speaking Platform.

WHERE
Brandman University
16355 Laguna Canyon Road, Room #111, Irvine, California 92618USA

WHEN
February 22, 2013
8:30 AM -4:00 PM

Attire
Business Attire

Fees
ASQ Section 701 Member: $130, if registered by February 15th

Non-Section Member: $150, if registered by February 15th

Further Details:

View Event Details

Event Agenda

RSVP by Friday, February 15 for discounted pricing!

January 28th, 2013

Drug Shortages from the FDA, Industry, and Consumer Perspectives

Orange County Regulatory Affairs Discussion Group (OCRA)

 Friday, February 22, 2013

8:00 am to Noon

Free of Charge
OCRA Membership is Required

(Employees of Host Locations do not need to be Members)

Four Locations To Choose From:   

Amgen
One Amgen Center Drive; Thousand Oaks, CA  91320

Beckman Coulter

250 South Kraemer Boulevard; Brea, CA 92821

 Bausch + Lomb

50 Technology Drive; Irvine, CA 92618

 Ardea

4939 Directors Place; San Diego, CA 92121

 (see below for driving directions to each location)

 

Program Managers:

Damon Jones, Vice President, Director of Operations, McGuff Pharmaceuticals, Inc.

 Tania Hoffman, MSRS, Sr. Regulatory Affairs Manager,  Spectrum Pharmaceuticals, Inc.

 Ruchika Raval, RAC, Principal, Global Biopharmaceutical Regulations, Inc.

Synopsis

Disruptions in the supply of potentially life-saving medications have become a critical public health issue. Many factors lead to prescription drug shortages.  Manufacturers are often unable to provide timely and complete information on the causes and potential resolution of these shortages to the public, which often leads pharmacies and healthcare facilities to try to find ways of avoiding negative outcomes in the patients they treat. In 2011, President Barack Obama signed an Executive Order directing the Food and Drug Administration to take on a greater role in reducing and preventing drug shortages. In 2012, Title X of the Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law, which lists the mandatory reporting requirements for manufacturers and provides FDA with important new authorities to help alleviate drug shortages. This program will look at drug shortages from the FDA, industry, and consumer perspectives and highlight efforts on all three fronts to manage this challenging issue.    

Speakers:

FDA Perspective 

Jeannie David, Program Management Officer, CDER Drug Shortage Program, FDA
(live from FDA Headquarters)

The speaker will discuss efforts underway at the FDA to address drug shortages, including interactions between the Agency and industry on manufacturing issues to maintain the safety and quality of medically necessary products while ensuring their continued availability.

 

Jeannie David, M.S. has been with the FDA since 2008. She is currently a Program Management Officer in the CDER Drug Shortage Program. She brings experience from her role as a Regulatory Health Project Manager in the CDER Office of New Drug Quality Assessment, the chemistry, manufacturing and controls (CMC) review division for new drug applications (NDAs), where she managed pre- and post-marketing applications, President’s Emergency Plan for AIDS Relief (PEPFAR) submissions, and presented a talk on Preparing for CMC Meetings with the FDA at the DIA 2012 Annual Meeting. Previously, Jeannie worked 7 years in the biopharmaceutical industry as a research scientist at Roche Palo Alto. She has a M.S. degree in neuroscience from the University of Wisconsin-Madison.  Ms. David will speak to us from Washington D.C.

 

Industry Perspective 

Scott McCarty, Risk Management Director, Amgen, Inc.
(Speaker will be at Amgen location) 

Scott McCarty has been with Amgen for 15 years, serving in a variety of roles in Operations and Quality Assurance. He is currently Director of Operations Risk Management, with responsibility for identification, characterization, and evaluation of risks to Amgen’s product supply chain. His prior Amgen experience includes leadership of a commercial product launch team and implementation of Amgen’s global change control system.

Prior to joining Amgen, Scott was a 20-year Navy fighter pilot, logging many aircraft carrier-based flight hours in F-4 and F-14 aircraft. Scott holds a bachelor’s degree in Economics from Stanford University, a master’s degree in Aeronautical Engineering from the Naval Postgraduate School, and the degree of Engineer in Aerospace Engineering from the University of Southern California.

 

Consumer Perspective

Speaker TBD
The speaker will discuss the effects of drug shortages on hospitals and patients.   

Schedule

8:00 – 8:45 am

Registration and Security Check In

Continental Breakfast 

 

8:45 – Noon  

Speaker Presentations 


REGISTRATION INSTRUCTIONS

  

For Amgen, Beckman Coulter and Ardea employees, please email Rob Fleming (rob.fleming@yahoo.com) with your name(s) and email addresses for each attendee.

All others please follow the instructions below. 

 

 

Be sure to log on and join or renew your OCRA Membership.  If you have not used our online system, you will need to create a new user profile before registering

http://www.ocra-dg.org/

  

Once you are logged on, click on “Register for a Meeting” on the right-hand side of the page. Next click on the meeting for which you would like to register, then follow the online instructions. You will receive an immediate confirmation.

CLICK HERE TO DOWNLOAD EVENT FLYER

 

Orange County Regulatory Affairs Discussion Group

5319 University Dr., Suite 641, Irvine, CA 92612

Tel:     949-387-9046

Fax:     949-266-8461 or 949-387-9047

Email: ksyre@cox.net

 

OCRA’s non-profit Federal Tax ID# 33-0630455    

 

 

DRIVING DIRECTIONS

 

Amgen

One Amgen Center Drive

Thousand Oaks, CA  91320

 

Note:  Please arrive at 8:00 am sharp as you need to be escorted to another building using Amgen’s shuttle.   

 

Please bring your photo ID for check in with Amgen security

Traveling Northbound on 405 and 101 Freeway

Take 405 Freeway North to 101 (Ventura) Freeway North.

Exit 47A Rancho Conejo Blvd.

Turn Right onto Ventu Park Road

Make a Left (before light at Pauling Dr.) into Building #37 parking lot.

Visitors to check in at Building #37 Lobby

Amgen Contact:  Amy Gonzales

Traveling Southbound on 101 Freeway

Traveling 101 S (towards Los Angeles)

Exit 47A, Borchard Rd. / Rancho Conejo Blvd.

Turn Left on Borchard Rd / Rancho Conejo Blvd

Continue to follow Rancho Conejo Blvd.

Turn Right on Ventu Park Road

Make a Left (before light at Pauling Dr.) into Building # 37 Parking Lot

Visitors to check in at Building #37 Lobby

Amgen Contact: Amy Gonzales

Beckman Coulter, Inc.

250 S. Kraemer Blvd.
Building #A
Brea, CA  92822

Directions from LA:
Take 405 S to 22 East.  Then take 57 N to Imperial Blvd.  Turn right onto  Imperial Blvd.  Go to the 5th Light and turn left onto Kraemer Blvd. Beckman Coulter will be on the right hand side.

Directions from San Diego:
Take 405 N to 55.  Then take 57 N to Imperial Blvd. Turn right at the end of the exit onto Imperial Blvd. Go to the 5th Light and turn left onto Kraemer Blvd.  Beckman Coulter will be on the right hand side.

Bausch + Lomb

50 Technology Drive

Irvine, CA 92618

 

From San Diego

Take 5 Freeway North

Exit at Alton Parkway (Exit 94B)

Turn Right onto Alton Parkway.

Take 1st Left  onto Technology Dr. W.

Bausch + Lomb will be on the Right.

 

From Long Beach

Take 405 Freeway South.

Exit at Irvine Center Drive (Exit 1C).

Turn Left onto Irvine Center Drive.

Turn Right onto Baranca Parkway.

Turn Left onto Technology Drive.

Bausch + Lomb will be on the Right.

Ardea

4939 Directors Place

San Diego, CA 92121

 

From San Diego Airport

Take 5 Freeway North.
Exit at Sorrento Valley Road (Exit 30).
Turn Left onto Roselle St.
Take the 1st Right onto Sorrento Valley Road.
Take the 2nd Right onto Vista Sorrento Pkwy.
Turn Left onto Directors Place.
Ardea will be on the Right.

From Oceanside
Take 5 Freeway South to 805 Freeway South.
Exit at Mira Mesa Blvd (Exit 27).
Turn Left onto Sorrento Valley Road.
Turn Left onto Vista Sorrento Pkwy.
Turn Right onto Directors Place.
Ardea will be on the Right.

January 7th, 2013

Data Analysis: Making the right decision & proving it!

The Southern California Discussion Group of the ASQ Biomedical Division in association with ASQ SFV section 706 Presents:
Data Analysis: Making the right decision & proving it!

An Industry Roundtable Discussion
Tuesday, Jan 15, 2013 5:30pm to 8:30pm
Topic: Assessing data, making decisions, & presenting the evidence
We will walk through many of the most commonly used statistical applications for Quality work and data analysis. Topics covered will include Data Distribution, Sampling and Sample Sizes, Hypothesis Testing, Control Charts, Gage R&R, and Capability Studies. Actual examples will be demonstrated for the use of these tools. A step-by-step approach will be shown using Minitab statistical software so feel free to bring your computer preloaded with Minitab to work live examples if you so desire. Many difficult topics will seem relatively easy by the end of this session.

Takeaways:
Know what to do with large data sets
Determine if data is normally distributed
Which tool to use for applying statistics to a project or process
Graph and interpret results from an analysis
Please bring your questions, experiences, and other commentary to make this a more valuable experience.

Expert: Larry Bartkus
Larry Bartkus has been named Speaker of the Year three times by ASQ Biomedical Southern California Discussion Group for his informative, interactive, and always humorous presentations. He is a Six Sigma Master Black Belt and ASQ Certified Quality Engineer with 40 years experience in the Quality Profession. Larry has extensive experience having held engineering and managerial positions in a variety of companies in the Biomedical industry including Master Black Belt for J&J, Supplier Quality Program Manager at ev3, and currently Distinguished Engineer at Edwards Life Sciences in Irvine, Ca. Larry is highly active and well known in the Quality Community having been Guest Speaker for The Society of Plastic Engineers, The Society of Manufacturing Engineers, APICS, ASQ, and 9 Colleges and Universities including USC. Larry is Past Chair for ASQ Section 702, San Gabriel Valley, and has served on their Executive Board for over 20 years. Larry is an Instructor for CQE, CQM, CQI Refresher Courses, and has conducted seminars on such topics as Six Sigma/Lean, Process Control, Statistical Sampling, Design of Experiments, etc. He has a wealth of knowledge to share with fellow Quality Professionals, both new and ‘seasoned’, and his open style of teaching and interacting with his audience makes the learning process enjoyable as well as highly effective.

Registration:
Dinner & drinks will be provided.
Seating is limited to the first 40 registrants so sign up soon! Registration closes at noon event day.
Member Early Registration $20-
Non-member Early Registration $30-
Walkins $30- cash only if seating is available
Registration: http://www.acteva.com//booking.cfm?bevaid=234545
Location: Baxter BioScience Auditorium, One Baxter Way, Westlake Village CA 91362

For more information Contact:
Dora Derashan (818) 693-6618 or email dderashan@yahoo.com
As volunteers in a not-for-profit professional organization ASQ Biomedical, SCDG (Southern California Discussion Group) is committed to providing low cost high value events for biomedical professionals and the local community. We are able to keep our costs low by utilizing a registration system that incurs minimal administrative overhead expenses and minimizes excess time and effort spent by our volunteers to bring you these events. Please help us continue providing low cost quality programs to you by using the system that works well for us. If you do not wish to use the registration system to preregister, you may attempt to register at the event, however seating is limited therefore entrance and/or food cannot be guaranteed. Also, due to the nature of the low pricing scheme and the registration system used, we are unable to perform refunds.

January 3rd, 2013

OCRA Supplements Update: What’s on the Horizon in 2013

Orange County Regulatory Affairs Discussion Group (OCRA)

Wednesday, January 9, 2013
12:30 pm – 5:00 pm
Location:
Irvine Marriott
18000 Von Karman, Irvine, CA 92612
949-553-0100

Program Managers:
Rogelio Rodriquez

Cameron B. Smith, J.D., Sr. Director, World Wide Regulatory, Government & Industry Affairs and Intellectual Property, Herbalife International of America

Vicki Whitsitt, Manager, Scientific and Regulatory Affairs, Natural Products Association

Schedule
12:30 – 1:00 p.m.
Registration

1:00 – 2:45 p.m.
Industry Update & What’s on the Horizon for 2013
Speakers:
Cara Welch, Ph.D., Vice President, Scientific & Regulatory Affairs, Natural Products Association (NPA)
and
Michael McGuffin, President, American Herbal Products Association (AHPA)
An industry update on regulatory activities that includes an update on current FDA activities including GMP inspections, GMP challenges with botanical dietary Ingredients & SAERs & a look at what’s ahead in 2013

2:45 – 3:00 p.m.
Break

3:00 – 3:45 p.m.
Testing and Laboratory Challenges
Speaker: Timothy Stewart, Ph.D., Consultant, QSD Consulting Group
Topics to Be Discussed:
1) FDA inspectors have developed and grown from entry level regulation curriculums. The harder questions are coming, how is your firm going to respond?
2) Specifications, raw material and finish product
3) Testing, raw material and finish product
4) Test appropriateness
5) Standards
6) Identification
7) Contamination
8) Sampling methods
9) Subset testing
10) What does that mean for your contract operations (manufacturing and laboratory)?
11) Qualified People
12) Corrective Action Reporting
13) OOS/OOT procedure
14) What does that mean for Quality Assurance and Regulatory Departments

3:45 – 4:30 p.m.
When to Call in the Experts
Speaker: Cameron Smith, J.D., Sr. Director, World Wide Regulatory, Government & Industry Affairs & Intellectual Property, Herbalife International of America

4:30 – 5:00 p.m.
Open Q&A with Speaker Panel
All presenters

Registration fee includes snacks, parking and access to electronic presentations (if approved by speakers for distribution).

About the Speakers
Michael McGuffin was honored in 2010 for over 20 years of dedicated service, having served as the President of the American Herbal Products Association (AHPA) and a member of the Board of Trustee’s for 10 years prior. He has been active in the herbal industry since 1974, having owned both retail and manufacturing businesses in this field.

A leading expert on dietary supplement regulation, Mr. McGuffin has been published in scholarly and scientific journals, including the Food and Drug Law Journal and Clinical Pharmacology & Therapeutics, and also wrote the highly-lauded publication AHPA’s Annotated Final Rule on Dietary Supplement cGMP (2007). Additionally, Mr. McGuffin served as Managing Editor of AHPA’s Botanical Safety Handbook (1997) and Herbs of Commerce, 2nd edition (2000). He speaks frequently on dietary supplement regulation in the U.S. and abroad.

Mr. McGuffin has represented the herbal industry at state and federal hearings on herbal regulatory issues. He has served as a member of the FDA’s Food Advisory Committee Working Group on Good Manufacturing Practices for Dietary Supplements (1998-99), the FDA’s Food Advisory Committee’s Dietary Supplements Subcommittee (2003-5) and currently serves on California’s Office of Environmental Health Hazard Analysis Food Warning Workgroup and the Advisory Board of the USC School of Pharmacy Regulatory Science Master’s Degree Program. He also serves on the boards of the American Herbal Pharmacopoeia, the American Association of Acupuncture and Oriental Medicine, and United Plant Savers.

Mr. McGuffin was awarded the Cliff Adler “Heart in Business” award in 1994 and the Nutrition Business Journal Award for Efforts on Behalf of Industry in 2004. Mr. McGuffin has been quoted in a variety of news publications such as the New York Times, the Washington Post, U.S. News & World Report and Newsweek and has made appearances on ABC’s Nightline, National Public Radio, and ABC Radio.

Cameron B. Smith, J.D., Senior Director, Regulatory, Government & Industry Affairs & Intellectual Property
Herbalife International of America
Cameron Smith has worked for Herbalife for eleven years and is one of the Company’s in-house attorneys. In addition to managing and protecting the Company’s intellectual property portfolio and handling a range of government-affairs responsibilities, he is the counsel of first resort for regulatory questions about foods, dietary supplements, and cosmetics, as well as product-related advertising and marketing issues. Admitted to practice in California, Louisiana, and Mississippi, Cameron earned his law degree at the University of Mississippi School of Law and his undergraduate degree at the University of Pennsylvania.

Timothy Stewart, Ph.D.,. QSD Consulting Group
Dr. Timothy Stewart is a retired professional athlete who became a scientist from University of Southern California. He has 10 years experience in oncology and chemistry laboratories using both modern instrumentation and classic compendia methods to bring better understanding of regulatory compliance to suppliers, manufacturers and marketers. Timothy has three years of experience with contract manufacturing of dietary supplements. Currently, he speaks, writes papers, audits, and works in a laboratory for the non-prescription drug, medical device, cosmetic, dietary supplement and food industries. He’s a consistent co-author for primary peer reviewed chemistry journals. In his spare time he can be found on the disc-golf course or riding waves in the ocean. You may view his profile at: http://www.linkedin.com/profile/view?id=48693551&trk=hb_tab_pro_top.

Cara Welch, Ph.D., Vice President, , Scientific & Regulatory Affairs Natural Products Association
Dr. Welch assists natural product industry members to implement policies in response to government initiatives in the regulatory and policy arena, and works with members of Congress and their staff, officials in the Food and Drug Administration (FDA), and other agencies whose actions have direct impact on the natural products industry. Additionally, she is responsible for advising association members on regulatory, safety, nutrition and health issues. Finally, she directs strategy development and provides guidance of the NPA Scientific and Regulatory programs, including the association’s Natural Certification for Personal Care and Home Care Products and Dietary Supplement GMP Certification.

Prior to joining the NPA, Dr. Welch studied at the department of Medicinal Chemistry at Rutgers University, under the direction of renowned plant biologist Dr. James E. Simon working on African botanicals and medicinal plants. She also studied with NPA Burton Kallman award winner Dr. Koji Nakanishi through the National Science Foundation’s Research Experience for Undergraduates (REU) award program. She earned her M.S. in Chemistry from the University of Iowa under Dr. James B. Gloer and her B.A. in Chemistry from Dordt College. She is a member of the American Chemical Society, American Society of Pharmacognosy and serves as a peer-reviewer for editorial boards.

Cost:
$135 OCRA Members
$185 Non Members
(includes OCRA Membership for one year)
$75 Student/Government Rate

REGISTRATION INSTRUCTIONS
Be sure to log on or create a new user profile before registering
http://www.ocra-dg.org/

Click Here to Download Registration Form for Fax Registrations

MULTIPLE REGISTRATIONS:
Our system is set up for one registration at a time. To register multiple people from your company, you can simplify the process by faxing us a cover page on your company letterhead listing the names of your attendees along with their title and email address.

SINGLE REGISTRATION:
Log on to the OCRA Web site with your username and password or create a new user profile:
http://www.ocra-dg.org/

Once you are logged on, click on “Register for a Meeting” on the right-hand side of the page. Next click on the meeting for which you would like to register, then follow the online instructions. You will receive an immediate confirmation.

If paying by personal or company check:
Please submit the online registration form. Mail your check made payable to OCRA to the following address:

Orange County Regulatory Affairs Discussion Group
5319 University Dr., Suite 641, Irvine, CA 92612
Tel: 949-387-9046
Fax: 949-266-8461 or 949-387-9047
Email: ksyre@cox.net

OCRA’s non-profit Federal Tax ID# 33-0630455

NOTE: We will ask for a credit card payment for any checks not received by the meeting date

Cancellation Deadline:
For a refund, please cancel by replying to this email by January 2, 2013.

If you have reserved a space but do not attend, your payment MUST be remitted.

DRIVING DIRECTIONS:
Irvine Marriott John Wayne Airport
18000 Von Karman Avenue, Irvine, CA 92612
Phone: 949-553-0100

From OC/John Wayne Airport:
Exit airport on Michelson Drive. Go straight to Von Karman Avenue and turn Left onto Von Karman Avenue. Turn Right onto Quartz and Left at the stop sign. The Marriott Hotel is on the left hand side.
From Long Beach Airport
or LAX – Los Angeles International Airport:
Take 405 South (San Diego Freeway). Exit Jamboree and turn Right off ramp. Turn Right onto Michelson Drive and Right onto Von Karman Avenue. Turn Right onto Quartz and Left at the stop sign. The Marriott Hotel is on the left hand side.

From Ontario International Airport:
Take 10 West (San Bernardino Freeway) to the 57 South (Orange Freeway). Take 57 South to the 5 South (Santa Ana Freeway). Take 5 South to the 55 South (Newport Beach Freeway) and then to 405 South (San Diego Freeway). Exit Jamboree, turn Right off ramp. Right onto Michelson Drive and Right onto Von Karman Avenue. Turn Right onto Quartz and Left at the stop sign. The Marriott Hotel is on the left hand side.
From Downtown Los Angeles:
Take 5 South (Santa Ana Freeway) to 55 South (Newport Beach Freeway). Take 55 South to 405 South (San Diego Freeway). Exit Jamboree and turn Right off the ramp. Turn Right onto Michelson Drive and Right onto Von Karman Avenue. Turn Right onto Quartz and Left at the stop sign. The Marriott Hotel is on the left hand side.
From San Diego:
Take 5 North (Santa Ana Freeway) to 405 North (San Diego Freeway). Exit Jamboree and turn Left off the ramp. Turn Right onto Michelson Drive and Right onto Von Karman Avenue. Turn Right onto Quartz and Left at the stop sign. The Marriott Hotel is on the left hand side.
From San Bernardino/Riverside:
Take 91 West (Riverside Freeway) to 55 South Freeway (Newport Beach Freeway). Take 55 south to 405 South Freeway (San Diego Freeway). Exit Jamboree Road, turn right off ramp. Turn Right onto Michelson Drive and Right onto Von Karman Avenue. Turn Right onto Quartz and Left at the stop sign. The Marriott Hotel is on the left hand side.

It is recommended that you look up driving directions from your own starting point.

Kimberly Syre
Attention To Detail
5319 University Dr., Suite 641
Irvine, CA 92612
Tel: 949-387-9046
Fax: 949-387-9047
Alt Fax: 949-266-8461
Email: ksyre@cox.net

October 15th, 2012

Medical Device Reporting Event: Inspections and Exemptions

Orange County Regulatory Affairs Discussion Group (OCRA)

Wednesday, November 7, 2012  

3:00 – 7:00 pm 


Location:   

Irvine Marriott

18000 Von Karman, Irvine, CA 92612 

949-553-0100

  Read the rest of this entry »

September 11th, 2012

Dietary Supplement Challenges: cGMPs, Analytical, FSMA,NDI, and More

 

The Food, Drug & Cosmetic Division of the American Society for Quality in cooperation with the United States Food and Drug Administration, Los Angeles District and the California Department of Public Health presents the 22nd Annual ASQ FDC West Coast Conference!

September 30, 2011

Paradise Pier Hotel at Disneyland Resort

Download Registration Flyer now!

September 7th, 2012

Southeast ASQ FDC/FDA Conference: Compliance 2012

 

Friday, September 28, 2012

7:45am-4:00pm

Sheraton Imperial Hotel
Research Triangle Park, NC

Keynote Speaker: Dara Corringan, FDA Associate Commissioner Read the rest of this entry »

May 8th, 2012

YOU BE THE JUDGE

One truck load of contaminated spinach can ruin your day…

as well as your organization’s reputation, workforce morale and bottom line.

On May 22, 2012, jump in the jury box and witness Frank Rothrock and Eva Weiler of Shook, Hardy & Bacon, Alonza E. Cruse of the U.S. Food and Drug Administration and Kellie Moore of MEIRxRS as they host a mock deposition demonstrating how to offensively prepare witnesses and investigate compliance practices.

Not for the queasy, this expert team will show you how your conduct can make or break your defense utilizing the reality, risks and perils of contaminated food.

Join us at the American Society for Quality (ASQ) World Conference for Quality and Improvement (WCQI) Mock Deposition at the Anaheim Convention Center Exhibit Hall A. Register at http://www.eventbrite.com/event/2945254335 to reserve your complimentary seat.

ALL NEWS MEDIA ARE WELCOME TO ATTEND. ASQ WCQI Mock Deposition Press Release 2012

Logos of our membershipsmore Logos of our memberships